Written by Eric Volkman for The Motley Fool ->
It had a good second quarter, fueled by sales growth in top blockbuster drugs.
It also topped analyst estimates for both revenue and profitability.
Sh
NA
Nasdaq News
31 Jul 2026 11 days ago 1 min read
Nasdaq News โ 31 July 2026
Text:
36 0 0
๐ Translate:
๐๏ธ AI Podcast โ Two-Host Discussion
Why AbbVie Stock Slumped Today
Kokoro TTS ยท ~5 min episode ยท American English voices
Choose voices for Host A and Host B. Changes take effect on next play.
A
Now Speaking
โ
Generating podcastโฆ
Synthesising speech โ will play automatically when readyโฆ
0:00 / 0:00
It had a good second quarter, fueled by sales growth in top blockbuster drugs.
It also topped analyst estimates for both revenue and profitability.